290 related articles for article (PubMed ID: 29309648)
1. An engineered RNA binding protein with improved splicing regulation.
Hale MA; Richardson JI; Day RC; McConnell OL; Arboleda J; Wang ET; Berglund JA
Nucleic Acids Res; 2018 Apr; 46(6):3152-3168. PubMed ID: 29309648
[TBL] [Abstract][Full Text] [Related]
2. Dissecting domains necessary for activation and repression of splicing by Muscleblind-like protein 1.
Edge C; Gooding C; Smith CW
BMC Mol Biol; 2013 Dec; 14():29. PubMed ID: 24373687
[TBL] [Abstract][Full Text] [Related]
3. MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T.
Warf MB; Berglund JA
RNA; 2007 Dec; 13(12):2238-51. PubMed ID: 17942744
[TBL] [Abstract][Full Text] [Related]
4. Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs.
Yuan Y; Compton SA; Sobczak K; Stenberg MG; Thornton CA; Griffith JD; Swanson MS
Nucleic Acids Res; 2007; 35(16):5474-86. PubMed ID: 17702765
[TBL] [Abstract][Full Text] [Related]
5. Cognate RNA-Binding Modes by the Alternative-Splicing Regulator MBNL1 Inferred from Molecular Dynamics.
González ÀL; Fernández-Remacha D; Borrell JI; Teixidó J; Estrada-Tejedor R
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555788
[TBL] [Abstract][Full Text] [Related]
6. MBNL proteins and their target RNAs, interaction and splicing regulation.
Konieczny P; Stepniak-Konieczna E; Sobczak K
Nucleic Acids Res; 2014; 42(17):10873-87. PubMed ID: 25183524
[TBL] [Abstract][Full Text] [Related]
7. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing.
Pascual M; Vicente M; Monferrer L; Artero R
Differentiation; 2006 Mar; 74(2-3):65-80. PubMed ID: 16533306
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic determinants of MBNL activity.
Sznajder ŁJ; Michalak M; Taylor K; Cywoniuk P; Kabza M; Wojtkowiak-Szlachcic A; Matłoka M; Konieczny P; Sobczak K
Nucleic Acids Res; 2016 Dec; 44(21):10326-10342. PubMed ID: 27733504
[TBL] [Abstract][Full Text] [Related]
9. Pseudouridine Modification Inhibits Muscleblind-like 1 (MBNL1) Binding to CCUG Repeats and Minimally Structured RNA through Reduced RNA Flexibility.
deLorimier E; Hinman MN; Copperman J; Datta K; Guenza M; Berglund JA
J Biol Chem; 2017 Mar; 292(10):4350-4357. PubMed ID: 28130447
[TBL] [Abstract][Full Text] [Related]
10. Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease.
Batra R; Charizanis K; Manchanda M; Mohan A; Li M; Finn DJ; Goodwin M; Zhang C; Sobczak K; Thornton CA; Swanson MS
Mol Cell; 2014 Oct; 56(2):311-322. PubMed ID: 25263597
[TBL] [Abstract][Full Text] [Related]
11. MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing.
Goers ES; Purcell J; Voelker RB; Gates DP; Berglund JA
Nucleic Acids Res; 2010 Apr; 38(7):2467-84. PubMed ID: 20071745
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of the RNA binding domain in the human muscleblind-like protein 2.
He F; Dang W; Abe C; Tsuda K; Inoue M; Watanabe S; Kobayashi N; Kigawa T; Matsuda T; Yabuki T; Aoki M; Seki E; Harada T; Tomabechi Y; Terada T; Shirouzu M; Tanaka A; Güntert P; Muto Y; Yokoyama S
Protein Sci; 2009 Jan; 18(1):80-91. PubMed ID: 19177353
[TBL] [Abstract][Full Text] [Related]
13. Structural Basis for Interaction of the Tandem Zinc Finger Domains of Human Muscleblind with Cognate RNA from Human Cardiac Troponin T.
Park S; Phukan PD; Zeeb M; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2017 Aug; 56(32):4154-4168. PubMed ID: 28718627
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing of the neurofibromatosis type 1 pre-mRNA is regulated by the muscleblind-like proteins and the CUG-BP and ELAV-like factors.
Fleming VA; Geng C; Ladd AN; Lou H
BMC Mol Biol; 2012 Dec; 13():35. PubMed ID: 23227900
[TBL] [Abstract][Full Text] [Related]
15. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
[TBL] [Abstract][Full Text] [Related]
16. MBNL splicing activity depends on RNA binding site structural context.
Taylor K; Sznajder LJ; Cywoniuk P; Thomas JD; Swanson MS; Sobczak K
Nucleic Acids Res; 2018 Sep; 46(17):9119-9133. PubMed ID: 29955876
[TBL] [Abstract][Full Text] [Related]
17. rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences.
Sellier C; Cerro-Herreros E; Blatter M; Freyermuth F; Gaucherot A; Ruffenach F; Sarkar P; Puymirat J; Udd B; Day JW; Meola G; Bassez G; Fujimura H; Takahashi MP; Schoser B; Furling D; Artero R; Allain FHT; Llamusi B; Charlet-Berguerand N
Nat Commun; 2018 May; 9(1):2009. PubMed ID: 29789616
[TBL] [Abstract][Full Text] [Related]
18. MBNL expression in autoregulatory feedback loops.
Konieczny P; Stepniak-Konieczna E; Sobczak K
RNA Biol; 2018 Jan; 15(1):1-8. PubMed ID: 28949831
[TBL] [Abstract][Full Text] [Related]
19. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy.
Kanadia RN; Shin J; Yuan Y; Beattie SG; Wheeler TM; Thornton CA; Swanson MS
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11748-53. PubMed ID: 16864772
[TBL] [Abstract][Full Text] [Related]
20. Zebrafish mbnl mutants model physical and molecular phenotypes of myotonic dystrophy.
Hinman MN; Richardson JI; Sockol RA; Aronson ED; Stednitz SJ; Murray KN; Berglund JA; Guillemin K
Dis Model Mech; 2021 Jun; 14(6):. PubMed ID: 34125183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
